Working… Menu

Safety and Immunogenicity of EXG-5003

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04863131
Recruitment Status : Recruiting
First Posted : April 28, 2021
Last Update Posted : April 30, 2021
Elixirgen Therapeutics, Inc.
Information provided by (Responsible Party):
Yohei Doi, Fujita Health University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 31, 2023
Estimated Study Completion Date : January 31, 2023